Introduction
============

The worldwide dissemination of bacteria producing New Delhi metallo-β-lactamase (NDM) is a major public health concern. NDM was first described for *Klebsiella pneumoniae* from a patient who was previously admitted to a hospital in India in 2009 ([@B32]). Since then, NDM producing bacteria have been identified in \>40 countries ([@B18]). Many reports have described patients who have visited NDM endemic areas, such as the Indian subcontinent and Balkan states, and then returning home with NDM-producing bacteria causing colonization or infection, and subsequent local spread ([@B23]). Molecular investigations have revealed that the spread of NDM involved complex pathways and a high level of inter-genus, -species, and -lineages gene transfer ([@B16]; [@B18]). Early reports further highlighted the involvement of diverse and heterogeneous NDM-carrying plasmids ([@B23]). However, it is possible that the epidemiology of NDM may change, as the gene may be carried by high risk international bacterial clones and epidemic resistance plasmids ([@B16]).

In China, reports of NDM-producing bacteria are on the rise, especially among *Enterobacteriaceae* from hospitalized patients ([@B31]; [@B34]; [@B6]). In 2012, our group reported the involvement of IncX3 plasmids (represented by pNDM-HN380) in the dissemination of *bla*~NDM-1~ in multiple geographic areas in China ([@B10]). Subsequently, pNDM-HN380-like plasmids carrying *bla*~NDM-1~ or variants have also been described in India, the Arabian Peninsula, Europe, and Australia ([@B26]; [@B24]; [@B25]; [@B2]; [@B13]). In a recent survey of more than a thousand carbapenem-resistant *Enterobacteriaceae* originating from hospitals located in 25 provinces and municipalities in China, the prevalence of *bla*~NDM~ was found to be 31% ([@B35]). Of note, *bla*~NDM~ was found to be harbored on IncX3 plasmids in a large majority (92%) of the *Escherichia coli* and *K. pneumoniae* isolates ([@B35]). In South Korea, among 146 NDM-producing *Enterobacteriaceae* recovered from 33 general hospitals in 2010--2015, IncX3 was the predominant plasmid type (77%) harboring *bla*~NDM~ ([@B33]).

The IncX plasmids are narrow host range plasmids of *Enterobacteriaceae* ([@B17]). These plasmids have been identified mainly from *Salmonella* and *E. coli* from diverse sources at low frequencies of 8.7 to 10.6% ([@B21]; [@B5]). In general, subtypes IncX1, IncX2, and IncX4 have been detected more commonly than IncX3 subtype ([@B5]). In this investigation, we studied the prevalence of IncX3 and other subtypes in a collection of carbapenem-resistant *Enterobacteriaceae* (CRE) originating from an active surveillance in Hong Kong. The biological features of the *bla*~NDM~-carrying IncX3 plasmids were investigated.

Materials and Methods {#s1}
=====================

Bacterial Isolates and Identification
-------------------------------------

A total of 198 CRE isolates, collected from 14 hospitals in Hong Kong in 2016 were investigated. The isolates were collected from a CRE surveillance program involving all the healthcare regions ([@B12], [@B8]). This comprised 109 carbapenemase-producing *Enterobacteriaceae* (CPE) and 89 carbapenemase-negative *Enterobacteriaceae* (CNE). The isolates (∼25%) were randomly selected from a total collection of 497 CPE and 331 CNE isolates in that year. Only one isolate from each patient was included. The species distribution for the final collection of CPE and CNE strains were, respectively, as follows: 49 and 30 *E. coli*, 32 and 38 *K. pneumoniae*, 11 and 8 *Enterobacter cloacae*, 6 and 3 *Citrobacter freundii*, 4 and 6 *Enterobacter aerogenes*, 4 and 1 *Klebsiella oxytoca*, and 3 and 3 other *Enterobacteriaceae*. The carbapenemase types in the isolates included NDM (*n* = 62), OXA-48 group (*n* = 21), IMP (*n* = 14), KPC (*n* = 8), and IMI (*n* = 4). The CPE isolates included 19 (17.4%) isolates from clinical specimens (including 3 blood cultures, 9 urines, 5 wounds, 1 bile fluid and 1 tracheal aspirate) and 90 (82.6%) isolates from rectal swabs. All except one CNE were recovered from rectal swabs. The isolates were identified to species level by MALDI-TOF MS ([@B1]) and were stored in MicroBank (Pro-Lab Diagnostics) at -80°C. All the isolates were retrospectively retrieved for this work.

Susceptibility Testing
----------------------

Disk diffusion method was used to determine the susceptibility of the isolates to ertapenem, imipenem, and meropenem (5). All the isolates were resistant to at least one of the carbapenem. Phenotypic expression of carbapenemase in the isolates was confirmed with a strip Carba NP test ([@B14]). For the subset of NDM-producing isolates carrying IncX3 plasmids, MICs of the carbapenems and a panel of drugs (amikacin, colistin, gentamicin, levofloxacin, minocycline, and tigecycline) with potential activities were determined by a broth microdilution procedure using Sensititre plates (Thermo Fisher Scientific, West Sussex, United Kingdom). Cation-adjusted Mueller-Hinton broth was used according to the manufacturer's recommendation. The plates were inoculated and the endpoints read after incubation in ambient air at 35°C for 18 h using a Thermo Fisher Scientific^TM^ Sensitre^TM^ ARIS^TM^ 2X instrument. Quality control was performed with *Pseudomonas aeruginosa* ATCC 27853 and *E. coli* ATCC 25922. EUCAST breakpoints were used for interpretation of colistin and tigecycline MIC ([@B7]). MICs for the other drugs were interpreted according to the CLSI ([@B3]).

Molecular Studies
-----------------

PCR assays were used to detect carbapenemase genes (*bla*~KPC~, *bla*~IMI~, *bla*~IMP~, *bla*~NDM~, *bla*~V\ IM~, and *bla*~OXA-48~). The allele of the carbapenemase genes were determined by Sanger sequencing ([@B8]; [@B19]). The isolates were surveyed for presence of the IncX1 to IncX5 subtypes plasmid replicons using previously described PCR procedures ([@B21]). The co-transfer of *bla*~NDM~ and the IncX3 plasmid was investigated by filter mating using J53 as the recipient. Transconjugants were selected on Luria-Bertani (LB) agar plates supplemented with sodium azide (100 μg ml^-1^) and meropenem (0.25 μg ml^-1^). Plasmid location of the *bla*~NDM~ and IncX3 replicon were confirmed by hybridization using specific PCR products as probes ([@B28]). PCR and Sanger sequencing was used to determine the multilocus sequence types (MLST) of *K. pneumoniae* and *E. coli* using the Pasteur Institute and the Warwick scheme, respectively ([@B4]; [@B30]).

Plasmid Sequencing
------------------

Thirteen isolates with the *bla*~NDM~ genes carried on IncX3 plasmids were sequenced. The isolates (one from blood culture, one from bile fluid and 11 from rectal swabs) were chosen to provide representation from different hospitals in the collection. The IncX3 plasmids carrying *bla*~NDM~ in the original isolates (*n* = 13) were sequenced by an Illumina HiSeq platform at ∼100-fold coverage. The plasmids were assembled *de novo* using a CLC Genomics Workbench (Qiagen, Redwood City, United States) and gaps were closed by additional PCRs and Sanger sequencing ([@B28]; [@B13]). ISfinder^[1](#fn01){ref-type="fn"}^ was used to identify and annotate insertion sequences.

Conjugation Studies
-------------------

The biological properties of two *bla*~NDM~-carrying IncX3 plasmids (both approximately 50 kb in size and carrying *bla*~CTX-M~ originating from two human *E. coli* strains CRE 396 and CRE 1493) and the IncFII plasmid pHK01 (70 kb, carrying *bla*~CTX-M-14~ from human *E. coli* isolate combat2D2, GenBank accession HM355591) were compared. pHK01 is an epidemic plasmid which plays an important role in the dissemination of *bla*~CTX-M-14~ among *E. coli* isolates in certain Asian countries ([@B11]; [@B15]). The frequencies of conjugational transfer of the plasmids to a panel of 11 isolates comprising *P. aeruginosa* (*n* = 3), *Acinetobacter baumannii* (*n* = 2), *E. coli* (*n* = 3, including J53 and two clinical isolates of ST131 and ST405), *Shigella flexneri* (*n* = 1), *Salmonella enteritidis* (*n* = 1), and *K. pneumoniae* (*n* = 1) were investigated. The two clinical *E. coli* isolates were chosen to represent two widespread clones of multilocus sequence types (ST) 131 and 405. In addition, the frequencies of plasmid transfer to J53 recipient was assessed at three different temperatures (30, 37, and 42°C). All conjugation, unless otherwise specified, were performed at 37°C at donor to recipient ratio of 1 to 2. Transconjugants were selected on either MacConkey, XLD, or UriSelect^TM^4 (Bio-Rad, CA, United States) agar plates containing supplemented sodium azide (100 μg ml^-1^), meropenem (0.25 μg ml^-1^) and/or cefotaxime (1 μg ml^-1^) as appropriate (**Supplementary Table [S1](#SM1){ref-type="supplementary-material"}**). The frequency of transfer was expressed as transconjugants per donor cell (T/D) as previously described ([@B36]). Donor and recipient cultures placed separately on filters were included as controls in each run and no growth was observed on the transconjugants selection media. All experiments were carried out four times (biological duplicates and technical duplicates) and mean values presented with standard deviations.

Statistical Analysis
--------------------

Proportions were compared using Chi-Square or Fisher exact tests. Conjugation frequencies were logarithmically transformed and compared using one way ANOVA. All analyses were performed using IBM SPSS Statistics, version 24 (Hong Kong). A two-tailed *P*-value of \<0.05 was considered as significant.

Results
=======

Prevalence of IncX Replicons
----------------------------

A total of 68 IncX replicons were detected in 64 isolates including 2 IncX1, 60 IncX3, and 6 IncX4 subtypes (**Table [1](#T1){ref-type="table"}**). There were differences in the relative occurrence of the IncX subtypes among the isolates. The IncX3 subtypes was more commonly found in NDM producers (75.8%, 47/62) than in isolates producing other types of carbapenemase (21.3%, 10/47, *P* \< 0.001) and carbapenemase non-producers (3.4%, 3/89, *P* \< 0.001).

###### 

IncX replicons among 198 carbapenem-resistant *Enterobacteriaceae* isolates.

  IncX subtype^a^   Number of isolates (% by column), according to carbapenemase type                            
  ----------------- ------------------------------------------------------------------- -------------- --------- -----------
  X1                2 (3.2)                                                             \-             \-        2 (1.0)
  X3                44 (71.0)                                                           9 (19.1)       3 (3.4)   56 (28.3)
  X4                \-                                                                  \-             2 (2.2)   2 (1.0)
  X3 and X4         3 (4.8)                                                             1 (2.1)        \-        4 (2.0)
  Total             49 (79.0)                                                           10 (21.3)^b^   5 (5.6)   64 (32.3)

a

No X2 and X5 replicons were detected.

b

X3 replicon was detected in isolates producing OXA-181 (

n

= 5), OXA-232 (

n

= 4), and KPC-2 (

n

= 1). One of the OXA-181 producers was also positive for the X4 subtypes

.

Characteristics of the NDM-Producing Isolates Carrying IncX3 Plasmids
---------------------------------------------------------------------

The 47 NDM-producing isolates carrying IncX3 plasmids were investigated further. The species of the isolates include 27 *E. coli*, 11 *K. pneumoniae*, 3 *E. cloacae*, 3 *E. aerogenes*, 2 *C. freundii* and 1 *K. oxytoca*. PCR and sequencing showed that the isolates had *bla*~NDM-1~ (*n* = 11), *bla*~NDM-5~ (*n* = 35), and *bla*~NDM-7~ (*n* = 1). In all the isolates, hybridization localized the *bla*~NDM~ gene to the IncX3 plasmids. All the IncX3 plasmids had size of approximately 50 kb. A wide diversity of sequence types (STs) were found among the *E. coli* and *K. pneumoniae* isolates. Among the 27 *E. coli* isolates, 22 different STs were identified. Two isolates each belonged to ST10, ST48, ST167, ST410, and ST744. The other isolates (*n* = 17) belong to single diverse STs (including ST156, ST224, ST354, ST522, ST617, ST641, ST718, ST761, ST877, ST964, ST1101, ST1147, ST2973, ST5229, and three new STs). The three new STs included a single locus variant (SLV) of ST10 (profile for *adk-fumC-gyrB-icd-mdh-purA-recA*, 605-11-4-8-8-8-2), a SLV of ST7122 (profile 623-11-4-12-8-new) and a ST with three new alleles (profile 87-new-136-new-new-1-157) (**Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}**). Among the 11 *K. pneumoniae* isolates, 10 different STs were identified including ST34 (*n* = 2) and nine single isolate STs (ST48, ST197, ST399, ST438, ST629, ST672, and three new STs). The three new STs included ST3386, ST3387, and ST3388. All except one *E. coli* isolate had ertapenem, imipenem, and meropenem MICs in the intermediate or resistant range (**Table [2](#T2){ref-type="table"}**). The only meropenem-sensitive isolate was intermediate to ertapenem and imipenem. Susceptibility rates were high (\>90%) for amikacin, colistin, and tigecycline. Co-resistance to levofloxacin, gentamicin, and minocycline were common.

###### 

Antimicrobial susceptibilities of the 47 NDM-producing isolates carrying IncX3 plasmids.

  Agent          \%     MIC~50~/MIC~90~ (μg/ml)   MIC range (μg/ml)               
  -------------- ------ ------------------------- ------------------- ----------- --------------
  Ertapenem      0      0                         100                 ≥16/≥16     2 to ≥16
  Imipenem       0      2.1                       97.8                ≥16/≥16     2 to ≥16
  Meropenem      2.1    2.1                       95.8                ≥16/≥16     1 to ≥16
  Levofloxacin   51.1   2.1                       46.8                2/≥8        ≤0.12 to ≥8
  Gentamicin     59.6   0                         40.4                ≤1/≥16      ≤1 to ≥16
  Minocycline    68.1   17.0                      14.9                2/≥16       ≤1 to ≥16
  Colistin       93.6   0                         6.4                 ≤0.25/0.5   ≤0.25 to \>4
  Amikacin       95.7   0                         4.3                 ≤4/≤4       ≤4 to ≥64
  Tigecycline    97.9   2.1                       0                   ≤1/≤1       ≤1 to 2

S, sensitive; I, intermediate; R, resistant. Colistin and tigecycline were interpreted according to EUCAST v8.1. All other drugs were interpreted according to 2018 CLSI M100

.

Complete sequences of 13 *bla*~NDM~-carrying IncX3 plasmids with sizes of ∼46 kb were obtained (**Supplementary Table [S2](#SM1){ref-type="supplementary-material"}**). This subset of isolates was randomly chosen from among the 47 NDM-producing isolates with IncX3 plasmids, including isolates from hospitals in six different healthcare regions. Twelve plasmids carried *bla*~NDM-5~ and one plasmid carried *bla*~NDM-1~. They have a plasmid scaffold typical of IncX3 plasmids. The genetic load regions in the plasmids were compared with two reference IncX3 plasmids (pIncX-SHV and pNDM-HN380) (**Figure [1A](#F1){ref-type="fig"}**). Features shared among the *bla*~NDM~-carrying plasmids include: (a) an IS*L3* with 8-bp flanking direct repeats (ATATGCAT) downstream of the resolvase gene; and (b) the *umuD* gene was split into two fragments (*umuDΔ*1 and *umuDΔ2*) at the same position resulting in a pair of 3-bp direct repeats (TGT). In the plasmids, *bla*~NDM~ was inserted as a putative IS*26*-IS*Aba125* transposon. The genetic load region in one plasmid carrying *bla*~NDM-1~ (pNDM-HK3694) was virtually identical to that in pNDM-HN380, except for a small deletion downstream of the IS*3000*. In ten *bla*~NDM-5~-carrying plasmids originating from different species (5 *E. coli*, 4 *K. pneumoniae*, 1 *E. cloacae*) and six hospitals, the sequences inserted between the two *umuD* fragments were 100% identical (10117 bp in length). This inserted sequence differs from that in pNDM-HN380 by a deletion of 7874 bp (**Figure [1A](#F1){ref-type="fig"}**). The remaining two plasmids exhibited one or two minor variations including an IS*1203* inserted within IS*3000* (pNDM-HK2967) or an additional deletion (616 bp) at the junction between the IS*5* and IS*Aba125*Δ1 remnant (pNDM-HK3774). In all the 12 NDM-5 plasmids, IS*5* was inserted at the same position leading to the flanking 4-bp direct repeats (CTAA). In the two NDM-1 plasmids (pNDM-HK3694 and pNDM-HN380), IS*5* was inserted at a different position in the opposite orientation.

![Analysis of IncX3 plasmid sequences in this study. **(A)** Comparison of genetic load regions in 13 plasmids harboring *bla*~NDM~ with two reference plasmids (pIncX-SHV and pNDM-HN380). **(B)** Phylogenetic analysis of 49 IncX3 plasmids using the Maximum Likelihood method based on the Tamura-Nei model. These included two reference plasmids, 13 plasmids in this study and 34 plasmids identified in GenBank (last accessed 16 May, 2018). Branches were drawn to scale, with lengths measured in the number of substitutions per site. Plasmids sequenced in the present study are marked with an asterisk. Each plasmid was labeled and color-coded by the geographical origin (blue intensity: high, Asia; moderate, Middle East; low, Europe and North America), host source (pink intensity: high, human; low, animals), and NDM allele (green intensity: high, allele 5; moderate, alleles 1 and 7; low, alleles 4 and 17).](fmicb-09-02272-g001){#F1}

Next, the complete sequence of pNDM-HK2998 (chosen as a representative) was used to query the GenBank database. This allowed identification of another 34 plasmids related to pNDM-HK2998 (**Figure [1B](#F1){ref-type="fig"}**), including 30 from Asia (China, Korea, Myanmar, India), two from Middle East countries (Oman, Kuwait), and one each from Italy and Canada. This comprised plasmids originating from human (*n* = 26) and food animals (*n* = 8). Multiple NDM variants (4, 5, 7, and 17) which differ from NDM-1 by one or more amino acids (V88L, D130N, M154L, and E170K) were carried by the plasmids. Alignment and phylogenetic analysis showed that the plasmids were highly similar in both the backbone and genetic load regions (**Figure [1B](#F1){ref-type="fig"}**).

Host Range and Conjugation Frequencies
--------------------------------------

In conjugation experiments, the IncX3 and IncFII plasmids could be successfully transferred from the original clinical strains to the *E. coli, S. flexneri, S. enteritidis*, and *K. pneumoniae* recipients (**Figure [2](#F2){ref-type="fig"}**). The highest frequencies of conjugative transfer of the IncX3 plasmids were observed for the *S. flexneri* and *S. enteritidis* recipients (≥10^-1^ per donor cell), following by the *K. pneumoniae* recipient (10^-2^ to 10^-3^ per donor cell). These conjugative frequencies were comparable or higher than those for the reference IncFII plasmid. Conjugation frequencies of the IncX3 plasmids in the *E. coli* recipients were variable; higher in the J53 recipient than in the two recipients of ST405 and ST131 lineages. In the latter two recipients, conjugation frequencies of the two IncX3 plasmids were lower than those for the reference IncFII plasmid. Despite repeated attempts, conjugative transfer of the IncX3 plasmids to *P. aeruginosa* and *A. baumannii* recipients was not successful.

![Conjugation frequencies of IncX3 and IncFII plasmids to six recipients of different species. The donor *E. coli* strains for the IncX3 plasmids (pNDM-HK1493 and pNDM-HK396) were CRE1493 and CRE396, respectively, while for the IncFII (pHK01) plasmid was combat2D2. The histograms show means and standard deviations (error bars). Conjugation frequencies were logarithmically transformed prior to statistical analysis.](fmicb-09-02272-g002){#F2}

Incubation temperatures had different effects on the transfer frequencies of the IncX3 and IncFII plasmids (**Figure [3](#F3){ref-type="fig"}**). At 30 and 37°C, conjugation frequencies of the IncX3 plasmids were comparable or higher (by 10^1^--10^3^-fold) than those for the reference IncFII plasmid. Incubation at 42°C inhibited the conjugative transfer of the IncX3 plasmids but not the IncFII plasmid.

![Conjugation frequencies of IncX3 and IncFII plasmids at three temperatures. The donor *E. coli* strains for the IncX3 plasmids (pNDM-HK1493 and pNDM-HK396) were CRE1493 and CRE396, respectively, while for the IncFII plasmid (pHK01) was combat2D2. The histograms show means and standard deviations (error bars). Conjugation frequencies were logarithmically transformed prior to statistical analysis.](fmicb-09-02272-g003){#F3}

Discussion
==========

This study demonstrated the importance of pNDM-HN380-like, IncX3 plasmids in the dissemination of *bla*~NDM~ among bacterial isolates of multiple *Enterobacteriaceae* species in Hong Kong. These plasmids can be considered epidemic because they have previously been detected in multiple countries and among bacteria of human and animal host sources ([@B10], [@B13]; [@B26]; [@B24]; [@B2]). Our isolates carrying IncX3 plasmids were mostly recovered from patients who have history of previous hospitalization in a healthcare institute either locally or in mainland China. In the collection, approximately three-quarters of them were rectal swab isolates which were detected through active surveillance culture upon hospital admission ([@B12]). It is likely that hospitals are the main reservoirs of these *bla*~NDM~ carrying plasmids. Additional reservoirs or sources of this resistance mechanism include commensals carried by food animals or household contacts of the patients ([@B9], [@B13]). In China, similar IncX3 plasmids carrying *bla*~NDM~ have been detected in *E. coli* from swine in Guangdong, Henan, and Hunan provinces and from a chicken in Shandong Province ([@B20]; [@B13]).

A high degree of synteny was demonstrated among the complete plasmid sequences in the present analysis. With the exception of a few insertions and deletions, insertion sequence elements bearing identical direct repeats and other genes within the genetic load regions harboring *bla*~NDM~ were shared between IncX3 plasmids from geographically widespread regions and host sources (**Figure [1](#F1){ref-type="fig"}**). The finding points to a single *bla*~NDM~ insertion into a common IncX3 plasmid ancestor (pNDM-HN380-like), rather than multiple, independent *bla*~NDM~ insertions in the IncX3 platform. Variants of *bla*~NDM-1~ then arise through single nucleotide substitution in the *bla*~NDM~ coding region. The NDM-1 variants that were identified in IncX3 plasmids including NDM-4, NDM-5, NDM-7, and NDM-17 have enhanced carbapenemase activity, leading to increased isolate resistance to carbapenem ([@B22]; [@B20]).

We showed that the IncX3 plasmids carrying *bla*~NDM~ could be transferred to different bacterial species at frequencies that are comparable or higher than the epidemic IncFII plasmid carrying *bla*~CTX-M~. The efficient transfer of *bla*~NDM~ plasmids to two clinical isolates of *S. flexneri* and *S. enteritidis* is concerning as this will render all the beta-lactam antibiotics ineffective. The conjugal transfer of the IncX3 plasmids carrying *bla*~NDM~ to recipient *E. coli* over a range of temperature is also of note. The finding has implications for the dissemination of *bla*~NDM~ in many environmental sources such as abiotic touch surface, sewage, waterway, and soil in tropical countries as well as in the guts of mammalian and avian species ([@B27]; [@B29]). In many Asian and Middle East countries, the ambient temperature in the summer is often above 30°C. Hence, this plasmid type may be more effective than the other plasmid types in the environmental dissemination of *bla*~NDM~ ([@B27]). Interestingly, the conjugal transfer of a related subtype, IncX4 at 30°C to recipient *E. coli* is also higher than IncFII, suggesting that this may be a property shared by all the subtypes of IncX plasmid ([@B21]).

Conclusion
==========

This study identified a highly conjugative, pNDM-HN380-like IncX3 plasmid to be a major vehicle for dissemination of *bla*~NDM~ among multiple enterobacterial species in Hong Kong hospitals. Analysis of complete plasmid sequences confirms that this epidemic NDM plasmid is widespread in the ecosystem.

Accession Numbers
=================

The complete sequences of the 13 IncX3 plasmids were deposited in the GenBank database under accession numbers MH234497 (pNDM-HK3871), MH234498 (pNDM-HK3855), MH234499 (pNDM-HK3836), MH234500 (pNDM-HK3819), MH234501 (pNDM-HK3816), MH234502 (pNDM-HK3774), MH234503 (pNDM-HK3712), MH234504 (pNDM-HK3706), MH234505 (pNDM-HK3694), MH234506 (pNDM-HK3473), MH234507 (pNDM-HK3218), MH234508 (pNDM-HK2998), and MH234509 (pNDM-HK2967).
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